http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012500254-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
filingDate 2009-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2012500254-A
titleOfInvention Methods and compositions for oral administration of proteins
abstract The present invention relates to a composition comprising a protein, an absorption enhancer, and a protease inhibitor, a method for treating diabetes mellitus including the step of administering the composition, and a step of orally administering a protein having enzyme activity. A method for oral administration is provided. [Selection] Figure 1
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019073541-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013501043-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021176913-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021167357-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7275207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021176914-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018505173-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015521610-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015515459-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018504444-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018504445-A
priorityDate 2008-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006111558-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007087957-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005281231-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006234913-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16186314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226602090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23683101

Total number of triples: 53.